The importance of these findings, besides stratification according to survival, is that there is an apparent subgroup of BAP1 loss patients that will not respond to chemotherapy at all, given that both WT1 and calretinin both are negative, a “triple-negative” subtype of mesothelioma (5/5 patients). Here, WT1 is linked to mesothelioma.